AOS has been recently shown to inhibit the expression of ST6GAL1 in human prostate cancer cells via the Hippo/YAP pathway, leading to altered expression profile of α-2,6-linked sialic acids [175]. Here, ST6GAL1 is linked to Familial prostate cancer.